These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3658956)

  • 1. [Antitoxic function of the liver and the effect of zixorin in patients with diabetes mellitus].
    Geller LI; Griaznova MV
    Probl Endokrinol (Mosk); 1987; 33(4):9-10. PubMed ID: 3658956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and elimination of antipyrine in man: an analysis of 298 patients classified by type of diabetes, age, sex, duration of disease and liver involvement.
    Sotaniemi EA; Pelkonen O; Arranto AJ; Tapanainen P; Rautio A; Pasanen M
    Pharmacol Toxicol; 2002 Mar; 90(3):155-60. PubMed ID: 12071338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipyrine clearance as a measure of drug metabolism in patients with diabetes mellitus].
    Oltmanns D; Dennin DE; Pentz R; Siegers CP
    Z Gastroenterol; 1984 Oct; 22(10):598-601. PubMed ID: 6506825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of caffeine in patients with decompensated type I and type II diabetes mellitus.
    Zysset T; Wietholtz H
    Eur J Clin Pharmacol; 1991; 41(5):449-52. PubMed ID: 1761072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of the antipyrine test in assessing liver function in patients with insulin-dependent diabetes mellitus].
    Khanina EV; Gorshteĭn ES; Michurina SP
    Probl Endokrinol (Mosk); 1990; 36(3):14-5. PubMed ID: 2395825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic drug metabolism is increased in poorly controlled insulin-dependent diabetes mellitus.
    Goldstein S; Simpson A; Saenger P
    Acta Endocrinol (Copenh); 1990 Nov; 123(5):550-6. PubMed ID: 2256435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The function of the monooxygenase system of the liver in patients with psoriasis].
    Chichenina IV
    Vestn Dermatol Venerol; 1989; (8):32-5. PubMed ID: 2816028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipyrine kinetics in undernourished diabetics.
    Shobha JC; Raghuram TC; Kumar AD; Krishnaswamy K
    Eur J Clin Pharmacol; 1991; 41(4):359-61. PubMed ID: 1804653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of type I and type II diabetes on antipyrine disposition in man.
    Zysset T; Wietholtz H
    Eur J Clin Pharmacol; 1988; 34(4):369-75. PubMed ID: 3402522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of type I and type II diabetes mellitus on antipyrine elimination.
    Adithan C; Danda D; Shashindran CH; Bapna JS; Swaminathan RP; Chandrasekar S
    Methods Find Exp Clin Pharmacol; 1989 Dec; 11(12):755-8. PubMed ID: 2626081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of fatty hepatosis in diabetics].
    Geller LI; Gladkikh LN; Griaznova MV
    Probl Endokrinol (Mosk); 1993; 39(5):20-2. PubMed ID: 8108340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of zixoryn on pharmacokinetics of antipyrine in intact and sensitized guinea pigs].
    Khlopushina TG; Krinskaia AV; Kovalenko LP; Zherdev VP; Val'dman AV
    Biull Eksp Biol Med; 1991 Jul; 112(7):67-9. PubMed ID: 1793861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of drug clearance in patients with diabetes mellitus & liver cirrhosis.
    Narang AP; Dutta DV; Khare AK
    Indian J Med Res; 1987 Mar; 85():321-5. PubMed ID: 3610277
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies.
    Goldfine AB; Simonson DC; Folli F; Patti ME; Kahn CR
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3311-20. PubMed ID: 7593444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic capacity of the liver in chronic alcoholic liver diseases].
    Adamska-Dyniewska H; Biernat S; Kulig A; Szeszko A; Tkaczewski W
    Pol Arch Med Wewn; 1981 Oct; 66(4):265-70. PubMed ID: 7335505
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contractile function of the myocardium and oxygen metabolism in diabetes mellitus].
    Balashov VA; Dikker VE; Galenok VA; Ibraeva MT
    Ter Arkh; 1985; 57(10):139-42. PubMed ID: 4081991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of pancreatic insulin reserve on the metabolic control of type I and II diabetes mellitus].
    Calle Fernández JR; Rubio Herrera MA; Calle Pascual AL; Bordíu Obanza E; Marañes Pallardo JP
    An Med Interna; 1994 Jul; 11(7):322-7. PubMed ID: 7981358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nicotinamide coenzymes in the regulation of cellular metabolism in various types of diabetes].
    Velikiĭ NN; Obrosova IG; Efimov AS; Babicheva EI; Sokil OP
    Vopr Med Khim; 1992; 38(4):45-52. PubMed ID: 1462505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of streptozotocin and dietary fructose on delta-6 desaturation in spontaneously hypertensive rat liver.
    Comte C; Bellenger S; Bellenger J; Tessier C; Poisson JP; Narce M
    Biochimie; 2004 Nov; 86(11):799-806. PubMed ID: 15589689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.